首页> 美国政府科技报告 >Analysis of the Threat of Genetically Modified Organisms for Biological Warfare
【24h】

Analysis of the Threat of Genetically Modified Organisms for Biological Warfare

机译:生物战中转基因生物威胁分析

获取原文

摘要

Evaluating the potential threats posed by advances in biotechnology, especially genetically modified organisms (GMOs) and synthetic biology remains a contentious issue. To better understand this issue, this study narrowed the scope of consideration in several dimensions. First, our analysis primarily focused on what we defined as a 'catastrophic biological attack', with a required level of damage more associated with biological warfare than bioterrorism. This damage would need to be direct in nature where the effect is more physical than psychological. Second, this biological attack would be restricted to the United States, not another nation or entity. In this sense, U.S. geography, climatology, infrastructure and medical systems play to counterbalance any potential biological attack. Even within a more narrow scope, there remains inherent complexity and uncertainty which, combined with the considerable rate of change for biotechnology, defies a simple, straightforward answer. We approached the issue by establishing an 'Analytical Framework.' The primary focus of the framework are those aspects of the technology directly affecting humans by inducing virulent infectious disease, or through expression of toxins or suppression of the immune response of target subjects. Parallel threats exist for animals and plants in the food chain and, secondarily, in the ecosphere. Although not specifically included in this analysis, those threats can also be evaluated within the analytical framework. To establish our analytical framework, we focused on the engineering of novel single-cell microorganisms previously unknown in nature as described by four conditions: 1. Modification of known pathogen microorganisms to new functionalities; 2. Modification of nonpathogens to become pathogenic; 3. Synthesizing pathogenic microorganisms de novo; 4. Synthesizing completely artificial or 'abiotic' pathogenic 'cells' or biomolecules.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号